AbraSilver Drilling at Diablillos Intercepts Wide Gold Intervals at Oculto East and Broad Silver Intercepts at JAC

Stock Information for NervGen Pharma Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About NervGen Pharma Corp.

AbraSilver Submits RIGI Application for the Diablillos Project
AbraSilver Continues to Drill High-Grade Gold at Diablillos, with 36 Metres of 2.32 g/t Gold Intersected at Oculto East
AbraSilver Drilling at Diablillos Intersects 8.5 Metres at 13.81 g/t Gold at Oculto East
ABRASILVER ANNOUNCES CLOSING OF BOUGHT DEAL LIFE OFFERING
AbraSilver Announces $43.4 Million "Bought Deal" Life Private Placement to Advance Diablillos Project
AbraSilver Appoints Marie Inkster as Director and Chair of the Board
AbraSilver Announces Filing of Technical Report for Updated Mineral Resource Estimate on the Diablillos Project
AbraSilver Extends Gold Zone at Diablillos Project with Additional Broad Intercepts at Oculto East

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.